Introduction: Antipsychotic-induced weight-gain (AIWG) is a very important, yet often
neglected side-effect in the treatment with first and second generation antipsychotics. AIWG …

People with severe mental illness, consisting of schizophrenia, bipolar disorder, and major
depression, have a high burden of modifiable cardiovascular risk behaviors and conditions …

Objectives: To provide advice and guidance regarding the management of mood disorders,
derived from scientific evidence and supplemented by expert clinical consensus to formulate …

The diagnosis of mental disorder initially appears relatively straightforward: Patients present
with symptoms or visible signs of illness; health professionals make diagnoses based …

Purpose Mental health disparities exist across several dimensions of social inequality,
including race/ethnicity, socioeconomic status and gender. Most investigations of health …

There are significant differences between men and women in the efficacy and tolerability of
antipsychotic drugs. Here, we provide a comprehensive overview of what is currently known …

Diabetes is highly prevalent in people with psychotic disorders, including schizophrenia and
schizoaffective disorders. Exact prevalence is difficult to estimate, since diabetes is often …

Objectives Health disparities between individuals of African and European ancestry are well
documented. The disparities in bipolar disorder may be driven by racial bias superimposed …

Background The association between cigarette smoking and schizophrenia is well
established. However, up to 90% of people with schizophrenia begin smoking before the …

Objective: To evaluate aripiprazole once-monthly (AOM), a long-acting injectable
suspension of aripiprazole, as acute treatment in patients with schizophrenia (DSM-IV-TR) …